Shaanxi adjusts the price limit of abiolone acetate and apixaban acetate
All medical institutions: according to the application of the enterprise, for abiolone acetate tablets (drug No.: 8184934, specification: 0.25g * 60 Tablets) and apixaban tablets (drug No.: 8185965, specification: 2.5mg) produced by Zhengda Tianqing Pharmaceutical Group Co., Ltd *The price limit of 14 tablets) was adjusted to 1436 yuan and 350 yuan respectively; the price limit of abitrone acetate tablets (drug No.: 8184933, specification: 0.25g * 120 tablets) produced by Chengdu Shengdi Pharmaceutical Co., Ltd. was adjusted to 3828 yuan. The adjusted price of the above-mentioned drugs shall be implemented from now on. Shaanxi public resources trading center February 18, 2020
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-08-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
-
Pharmaceutical and Health Industry Special Study - The Arrival of New Opportunities
-
Accelerate Technological Breakthroughs in Product Innovation and Promote the Industrialization and Application of Innovative Drugs
Recommend Reading
-
Saudi Aramco’s 400,000 bpd Jazan Refinery Shuts After Attack
-
Japan Extends Bisphenol A Anti-Dumping Probe, Prolonging Uncertainty for Korean and Taiwanese Suppliers
-
Sumitomo Chemical Launches Pilot Plant for Ethanol-to-Propylene Process
-
The Cold Cycle: PVC Market’s Chill and Faint Light Ahead
-
Echoes of Overcapacity: The Structural Anxiety of China’s EVA Industry Chain
-
Supply Tightening Dominates the Market, Acrylic Acid Prices Steady with an Uptick
-
Methylene Chloride Market Hits Bottom and Stabilizes, with Supply Contraction Driving a Moderate Recovery
-
Melamine Stops Falling and Begins to Rebound; Short-Term Trend Strengthens; Golden Cross Awaits Confirmation
-
Recent EVA Market Trends Continue to Rise in China
-
US-Iran Signals Easing, Plasticizer Supply Chain Stabilizes